by Schrodinger
LiveDesign is Schrödinger's cloud-native platform where drug discovery teams design molecules, run predictions, analyze data and collaborate in one interface. It covers small molecules, biologics and materials science.
Web appContact for pricing
Step 1: Request a demo from the Schrödinger LiveDesign page.
Step 2: Connect your project data and any corporate data sources.
Step 3: Capture design ideas and hypotheses for the project.
Step 4: Run predictive models and review results alongside experimental data.
Step 5: Build dashboards to track compounds and share decisions with the team and partners.
A cloud-native environment where discovery teams design, predict, analyze and collaborate on molecules in a single interface.
Yes. The page lists LiveDesign for biologics alongside small molecules and materials science.
Yes. Web-based or in-house tools and corporate data sources can be snapped in through an API.
The page features LiveDesign ML for training and deploying AI/ML property prediction models for small molecules.
Nabla BioNabla Bio applies AI to AI protein design platform for creating antibodies and therapeutic proteins against challenging membrane and soluble targets.
Relay Therapeutics DynamoRelay Therapeutics Dynamo applies AI to computational drug discovery platform modeling protein motion and molecular interactions to design targeted medicines.
XineDiscoverXineDiscover is Xineplus's closed-loop AI drug discovery platform. It generates drug-like molecules, screens them against protein targets, predicts ADMET properties and optimizes lead candidates.